These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27108649)

  • 1. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
    Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
    Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.
    Wang Q; Tang H; Yin S; Dong C
    Oncol Rep; 2013 May; 29(5):2046-52. PubMed ID: 23446431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
    Zhao Y; Zong ZH; Xu HM
    Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
    Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.
    Yang H; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Zhao H; Li E
    Oncol Rep; 2015 Oct; 34(4):1681-91. PubMed ID: 26260613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
    Iiizumi M; Bandyopadhyay S; Pai SK; Watabe M; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Furuta E; Liu W; Xing F; Okuda H; Kobayashi A; Watabe K
    Cancer Res; 2008 Sep; 68(18):7613-20. PubMed ID: 18794150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
    Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
    Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.
    Chu CH; Chou W; Wang F; Yeh CN; Chen TC; Yeh TS
    J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
    Qiao B; Johnson NW; Gao J
    Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
    PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.